CLOV stock

Is Clover Health Investments Corp (CLOV) overvalued? · rev $1.37B

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

This page asks whether Clover Health Investments Corp (CLOV) looks expensive on cached numbers — not a short thesis.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

CLOV currently screens at market cap $1.55B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next CLOV 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the CLOV stock page for the full model, not this heading.

Not investment advice.

Full CLOV analysis